Načítá se...
Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells
Immunoglobulin E (IgE) plays a key role in allergic asthma and is a clinically validated target for monoclonal antibodies. Therapeutic anti-IgE antibodies block the interaction between IgE and the Fc epsilon (Fcε) receptor, which eliminates or minimizes the allergic phenotype but does not typically...
Uloženo v:
| Vydáno v: | Cell Mol Immunol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4856805/ https://ncbi.nlm.nih.gov/pubmed/25942513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cmi.2015.19 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|